Trientine Hydrochloride (Innolife )

盐酸曲恩汀（因诺生物）

Report date: 2024/11/22 20:00:28

Base Information

Drug NameTrientine Hydrochloride (Innolife )
Drug Alias NameINL1INL-1
ClassificationSmall molecules > Polymers and chelators
Mechanisms of ActionChelating agents
TargetsNot applicable
Therapy Area/IndicationsHeart Failure, SystolicHeart Failure
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesMainland China
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaPending
Originator CompaniesInnolife Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesInnolife Co Ltd
Active IndicationsN/A
Inactive IndicationsHeart Failure, SystolicHeart Failure

Other Information

ATC CodeN/A
Related LinksN/A